Gabor Kari

Gabor Kari, MD, is a seasoned medical professional currently serving as the Senior Director of Clinical Biomarkers at GSK since November 2023. Prior experience includes roles as US Medical Director and US Regional Medical Director at Novartis, focusing on novel immuno-oncology combinations involving checkpoint inhibitors, and as Precision Medicine Associate Director at Adaptimmune. Gabor Kari’s career also encompasses significant research contributions at the University of Pennsylvania and Thomas Jefferson University, including studies on radiation toxicity and gene therapy. Educational credentials include an MD from the University of Debrecen and early studies at West Chester University and Radnor Senior High School.